Blood Culture Tests Market Trends

Growth Drivers

Growth Strategies Integration by Market Players - Growth strategies include new product launches, mergers and acquisitions, obtaining investment from prominent companies to provide consumers with innovative and safe products, strengthening our product offerings, expanding our customer base, and expanding our market reach. This includes strengthening our presence and expanding our geographic footprint. We are currently seeing an increasing trend in the market towards these strategies. In March 2023, BARDA and BioFire Defense, LLC partnered to advance the development of Specific Diagnostics' SPECIFIC Reveal Rapid AST system. The platform is designed to test for antibiotic susceptibility in a rapid and modular manner, providing phenotypic results from positive blood cultures or isolates in an average of just 5.5 hours. Thus, growing number of growth strategies introduced by market players is significantly driving the expansion of the market in the estimated timeframe.
Blood Culture Out Space Solid Media Culture Plates - The requirement for a lengthy culture period on solid media has been considered a limitation of MALDI-TOF, as it delays time to patient diagnosis. By comparison, nucleic acids isolated directly from biological samples can be subjected to molecular techniques such as polymerase chain reaction (PCR) and do not require additional incubation time. The concentration of host proteins also contributes to the bacterially attributed and masked spectral information, making it impossible to analyze microorganisms using MALDI-TOF directly from biological samples such as blood or urine.

Challenges

Lack of Skilled Laboratory Technicians - It is well known that lab-based diagnostic tests are the most important volume activity of the medical industry. In almost all cases, patients who visit a healthcare establishment are treated with clinical laboratory tests. Despite the growing demand for skilled workers in the laboratory sector, there is a severe shortage of them.
False Positive Results of the Test are Expected to Hamper the Market Growth in the Forecast Period
High Cost of Test is Set to Pose Limitation on the Market Growth in the Upcoming Period

Blood Culture Tests Market: Key Insights

Base Year	2024
Forecast Year	2025-2037
CAGR	11.8%
Base Year Market Size (2024)	USD 6.64 billion
Forecast Year Market Size (2037)	USD 28.31 billion
Regional Scope	North America (U.S., and Canada) Latin America (Mexico, Argentina, Rest of Latin America) Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific) Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of blood culture tests is evaluated at USD 7.27 billion.

Blood Culture Tests Market size was valued at USD 6.64 billion in 2024 and is projected to exceed USD 28.31 billion by the end of 2037, expanding at over 11.8% CAGR during the forecast period i.e., between 2025-2037. The growing cases of HAI and growth strategies by market players will drive the market growth.

Asia Pacific industry is estimated to hold largest revenue share of 33% by 2037, as blood cultures are becoming a more important tool to help identify the best course of therapy and promote effective management.

The major players in the market are of F. Hoffmann-La Roche AG, Cepheid, Scenker Biological Technology Co., Ltd, Bio-Rad Laboratories, Inc., TERUMO BCT, INC., bioMÃƒÂ©rieux SA, and others.

Blood Culture Tests Market Trends